Twin Tree Management
ARNA

Twin Tree Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Twin Tree Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-131
Closed -$6K – 1539
2019
Q3 		$6K Buy
+131
New +$7.36K ﹤0.01% 1169

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Twin Tree Management's ARNA Position: Q4 2019 in Review

Twin Tree Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2019, closing a stake of 131 shares — an estimated $6K sold.

Twin Tree Management first reported a position in ARNA in Q3 2019 and held it in 1 quarter. The position peaked at $6K in Q3 2019. 226 funds tracked by Wall St. Rank hold ARNA as of Q4 2019.

  • Twin Tree Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
  • Twin Tree Management sold 131 Arena Pharmaceuticals Inc shares in Q4 2019, an estimated $6K.
  • Twin Tree Management first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 1 quarter.
  • Twin Tree Management's Arena Pharmaceuticals Inc position peaked at $6K in Q3 2019.
  • 226 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2019.

Based on Twin Tree Management's 13F filing for Q4 2019, filed 14 Feb 2020.